Rachael Nokes serves as Executive at scPharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Rachael Nokes has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 7, 2025 involved transacting 30,386 shares valued at $0.
Rachael Nokes currently holds 125,675 shares of scPharmaceuticals Inc. (SCPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rachael Nokes has been a net neutral trader of SCPH stock. They have purchased $0 and sold $0 worth of shares.
Rachael Nokes's most recent insider trade was on Oct 7, 2025, when they sold 30,386 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 6, 2024 | SCPH | $0 | Option Exercise | 10,445 | $N/A | Discretionary |
| Aug 6, 2024 | SCPH | $17.3K | Option Exercise | 10,445 | $1.66 | Discretionary |
| Jan 18, 2024 | SCPH | $0 | Award | 41,840 | $N/A | Discretionary |
| Jan 2, 2024 | SCPH | $6.6K | Payment | 1,027 | $6.39 | Discretionary |
| Jan 19, 2023 | SCPH | $71.8K | Award | 11,700 | $6.14 | Discretionary |
| Feb 25, 2021 | SCPH | $14.4K | Payment | 1,976 | $7.27 | Discretionary |
| Feb 25, 2020 | SCPH | $20.0K | Payment | 1,981 | $10.09 | Discretionary |